scholarly journals Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome

2017 ◽  
Vol 52 (11) ◽  
pp. 1530-1536 ◽  
Author(s):  
D Modi ◽  
A Deol ◽  
S Kim ◽  
L Ayash ◽  
A Alavi ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document